{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "currency": "USD", "priceEpsCurrentYear": -2.3770492, "sharesOutstanding": 8159640, "bookValue": 5.76, "fiftyDayAverage": 2.5003, "fiftyDayAverageChange": 0.39970016, "fiftyDayAverageChangePercent": 0.1598609, "twoHundredDayAverage": 5.388185, "twoHundredDayAverageChange": -2.488185, "twoHundredDayAverageChangePercent": -0.46178535, "marketCap": 23921404, "forwardPE": -1.5425533, "priceToBook": 0.5034722, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "averageAnalystRating": "1.7 - Buy", "tradeable": false, "cryptoTradeable": false, "exchange": "NGM", "shortName": "Bionomics Limited - American De", "longName": "Bionomics Limited", "messageBoardId": "finmb_3331473", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "PRE", "regularMarketChangePercent": 13.94892, "regularMarketPrice": 2.9, "firstTradeDateMilliseconds": 1639665000000, "priceHint": 4, "preMarketChange": 0.18999982, "preMarketChangePercent": 6.5517173, "preMarketTime": 1684234800, "preMarketPrice": 3.09, "regularMarketChange": 0.35500002, "regularMarketTime": 1684180795, "regularMarketDayHigh": 3.17, "regularMarketDayRange": "2.55 - 3.17", "regularMarketDayLow": 2.55, "regularMarketVolume": 79320, "regularMarketPreviousClose": 2.545, "bid": 0.0, "ask": 3.27, "bidSize": 10, "askSize": 12, "fullExchangeName": "NasdaqGM", "financialCurrency": "AUD", "regularMarketOpen": 2.55, "averageDailyVolume3Month": 146365, "averageDailyVolume10Day": 13860, "fiftyTwoWeekLowChange": 1.1000001, "fiftyTwoWeekLowChangePercent": 0.6111112, "fiftyTwoWeekRange": "1.8 - 10.9", "fiftyTwoWeekHighChange": -7.9999995, "fiftyTwoWeekHighChangePercent": -0.73394495, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 10.9, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -2.48, "epsForward": -1.88, "epsCurrentYear": -1.22, "displayName": "Bionomics", "symbol": "BNOX"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "200 Greenhill Road", "city": "Eastwood", "state": "SA", "zip": "5063", "country": "Australia", "phone": "61 8 8150 7400", "website": "https://www.bionomics.com.au", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers. The company's lead drug candidate includes BNC210, a negative allosteric modulator of the a7 nicotinic acetylcholine receptor, which is in phase 2 clinical trial for the treatment of social anxiety disorder and phase 2b to treat post-traumatic stress disorder. It also develops BNC101, a monoclonal antibody that has completed phase 1 clinical trial that targets cancer stem cells; and BNC105, which is in phase 2 clinical trial for the treatment of refractory colorectal cancer and phase 1 clinical trial for the treatment of patients with relapsed/refractory chronic lymphocytic leukemia. Bionomics Limited was incorporated in 1996 and is based in Eastwood, Australia.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Adrian  Hinton BEC, F.C.A.", "age": 70, "title": "Acting Chief Financial Officer", "yearBorn": 1952, "fiscalYear": 2022, "totalPay": {"raw": 215184, "fmt": "215.18k", "longFmt": "215,184"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Connor  Bernstein M.Sc.", "age": 34, "title": "VP of Strategy & Corp. Devel.", "yearBorn": 1988, "fiscalYear": 2022, "totalPay": {"raw": 229273, "fmt": "229.27k", "longFmt": "229,273"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Spyridon  Papapetropoulos M.D., Ph.D.", "age": 48, "title": "CEO, Pres & Director", "yearBorn": 1974, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Prof. Paul  Rolan D.C.P.S.A., F.F.P.M., F.R.A.C.P., M.B.B.S., M.D.", "title": "Consultant Chief Medical Officer of Clinical Neuroscience", "fiscalYear": 2019, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Suzanne  Irwin B.Com., FCIS", "title": "Company Sec.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}